Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

600
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
600
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

580
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
580
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

369
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
369
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

347
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
347
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

549
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
549
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

327
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
327

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI).

Arthritis care & researchยท2026
Same author

Challenges and Future Trends in Large Vessel Vasculitis.

Circulationยท2026
Same author

GPR15-guided CD8<sup>+</sup> T regulatory cells control intestinal inflammation.

Natureยท2026
Same author

Cutaneous Manifestations of Vasculitis: A Cross-Sectional Analysis From an International Cohort.

International journal of dermatologyยท2026
Same author

A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritis.

Seminars in arthritis and rheumatismยท2026
Same author

18F-Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment Within a Randomized Controlled Trial in Giant Cell Arteritis.

Arthritis & rheumatology (Hoboken, N.J.)ยท2026

Related Experiment Video

Updated: Apr 12, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

734

What matters for patients with vasculitis?

Elaine Novakovich1, Peter C Grayson1

  • 1National Institutes of Health/NIAMS, Vasculitis Translational Research Program, Bethesda, MD 20892, United States.

Presse Medicale (Paris, France : 1983)
|May 20, 2015
PubMed
Summary

Improved vasculitis survival brings chronic disease challenges. Patient quality of life suffers from disease burden, side effects, and relapse fears, necessitating patient-centered care.

Area of Science:

  • Rheumatology
  • Clinical Medicine
  • Patient-Reported Outcomes

Background:

  • Advances in vasculitis clinical care have increased survival rates.
  • Chronic vasculitis management presents ongoing challenges, impacting patient quality of life.
  • Key issues include lack of curative treatments, disease burden, side effects, and fear of relapse.

Purpose of the Study:

  • To highlight the shift towards understanding vasculitis from the patient's perspective.
  • To emphasize the need for research and outcome measures that reflect the patient experience.
  • To advocate for healthcare providers to address the comprehensive medical and biopsychological needs of vasculitis patients.

Main Methods:

  • Literature review and synthesis of current challenges in vasculitis care.

More Related Videos

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

5.3K

Related Experiment Videos

Last Updated: Apr 12, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

734
Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

5.3K
  • Analysis of patient-reported outcomes and quality of life data.
  • Discussion of evolving research paradigms focusing on patient-centered approaches.

    • Main Results:

    • Patient-perceived quality of life is significantly reduced due to disease burden and treatment.
    • Discrepancies exist between patient beliefs and healthcare provider perspectives on vasculitis.
    • There is a growing emphasis on developing patient-centered outcome measures.

    Conclusions:

    • Healthcare providers must acknowledge the substantial burden of vasculitis on patients' lives.
    • Comprehensive care addressing both medical and biopsychological needs is crucial.
    • Future research should prioritize patient-reported outcomes and experiences in vasculitis management.